Abstract
This IRB-approved prospective exploratory study was designed to reduce acute post-surgery pain levels after adoption of a multimodal analgesic protocol including bupivacaine liposomal suspension for third molar surgery in 2018.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
Paper Title
Journal
Date
